Cancer combination therapies by angiogenesis inhibitors; a comprehensive review

The biology and role of CD44 in cancer progression: therapeutic implications

Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma

Different expression of CD44, ICAM-1, and HSP60 on primary tumor and metastases of a human pancreatic carcinoma growing in scid mice.